IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -146.96% | 7.74% | 158.24% | -55.36% | 143.57% |
| Total Depreciation and Amortization | -33.33% | -39.39% | -4.55% | -56.36% | 103.66% |
| Total Amortization of Deferred Charges | 29.01% | -64.67% | 12.46% | 6.34% | 21.66% |
| Total Other Non-Cash Items | 61.31% | 8.22% | -317.13% | 138.60% | -457.47% |
| Change in Net Operating Assets | 529.01% | 2,021.15% | 875.61% | 547.60% | 66.28% |
| Cash from Operations | 70.38% | 100.00% | 100.00% | 70.15% | 51.03% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | 100.00% | 100.00% | 70.20% | 55.68% |